Quotient Wealth Partners LLC Increases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Quotient Wealth Partners LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,522 shares of the medical equipment provider’s stock after acquiring an additional 82 shares during the quarter. Quotient Wealth Partners LLC’s holdings in Intuitive Surgical were worth $748,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. One Wealth Management Investment & Advisory Services LLC boosted its stake in shares of Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after buying an additional 23 shares in the last quarter. Daymark Wealth Partners LLC raised its position in Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock worth $3,452,000 after acquiring an additional 24 shares in the last quarter. Indiana Trust & Investment Management CO lifted its holdings in Intuitive Surgical by 5.3% in the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after acquiring an additional 25 shares during the period. Hoxton Planning & Management LLC boosted its position in shares of Intuitive Surgical by 4.9% during the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after purchasing an additional 25 shares in the last quarter. Finally, True North Advisors LLC grew its stake in shares of Intuitive Surgical by 2.1% during the 3rd quarter. True North Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock worth $605,000 after purchasing an additional 25 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, insider Mark Brosius sold 2,115 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the transaction, the insider now directly owns 295 shares in the company, valued at approximately $145,113.45. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Intuitive Surgical news, insider Mark Brosius sold 2,115 shares of Intuitive Surgical stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the sale, the insider now owns 295 shares in the company, valued at $145,113.45. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 1,413 shares of the stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $438.60, for a total transaction of $619,741.80. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,414,931.60. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 53,120 shares of company stock valued at $25,528,753. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Royal Bank of Canada raised their price objective on shares of Intuitive Surgical from $515.00 to $525.00 and gave the company an “outperform” rating in a research note on Tuesday. Citigroup lifted their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $475.00 to $495.00 and gave the stock an “overweight” rating in a research note on Friday, July 19th. Truist Financial raised their price objective on Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research note on Tuesday, July 16th. Finally, Morgan Stanley lifted their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a report on Monday, July 15th. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $454.35.

Intuitive Surgical Trading Down 1.3 %

Shares of ISRG stock opened at $483.84 on Friday. The company has a market capitalization of $171.93 billion, a price-to-earnings ratio of 83.13, a PEG ratio of 5.40 and a beta of 1.39. The firm has a 50-day moving average price of $478.98 and a 200 day moving average price of $433.69. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $496.48.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The business had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company’s revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.18 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.